NIBEC CO., LTD. Logo

NIBEC CO., LTD.

Biotech CDMO creating regenerative products with peptide and biomaterial technologies.

138610 | KO

Overview

Corporate Details

ISIN(s):
KR7138610001
LEI:
Country:
South Korea
Address:
충청북도 진천군 이월면 밤디길 116 이월전기전자농공1단지, 진천군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NIBEC Co., Ltd. is a biotechnology company focused on developing innovative healthcare solutions through regenerative medicine. The company specializes in the research, development, and commercialization of products based on its core expertise in bioactive peptide technology and advanced biomaterials. Its primary offerings include tissue regenerative products, such as dental bone grafts and collagen-based materials, as well as peptide-based smart materials and bio-fusion products for medical applications. Additionally, NIBEC operates as a Contract Development and Manufacturing Organization (CDMO), providing cGMP-compliant custom peptide synthesis and manufacturing services to the pharmaceutical and biotech sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-05 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 903.3 KB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-04 00:00
Share Issue/Capital Change
전환청구권행사
Korean 11.5 KB
2025-05-28 00:00
M&A Activity
투자판단관련주요경영사항 (NP201 기술이전의 건)
Korean 13.8 KB
2025-05-22 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.1 KB
2025-05-22 00:00
Share Issue/Capital Change
전환가액의조정
Korean 12.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 815.7 KB
2025-04-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.2 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 993.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.1 KB
2025-03-20 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 21.2 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 101.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 92.6 KB

Automate Your Workflow. Get a real-time feed of all NIBEC CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NIBEC CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NIBEC CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland
IDIA
IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America
IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.